Eran Broshy's Net Worth

$16.8 Million

Estimate Recalculated Nov 1, 2024 04:55AM EST

Who is Eran Broshy?

Eran Broshy has an estimated net worth of $16.8 Million. This is based on reported shares across multiple companies, which include MAGELLAN HEALTH SERVICES INC, Theravance Biopharma, Inc., Certara, Inc., NEUROGEN CORP, UNION STREET ACQUISITION CORP., and VENTIV HEALTH INC.

SEC CIK

Eran Broshy's CIK is 0001256230

Past Insider Trading and Trends

2005 was Eran Broshy's most active year for acquiring shares with 19 total transactions. Eran Broshy's most active month to acquire stocks was the month of April. 2007 was Eran Broshy's most active year for disposing of shares, totalling 23 transactions. Eran Broshy's most active month to dispose stocks was the month of April. 2006 saw Eran Broshy paying a total of $9,172,925.00 for 361,250 shares, this is the most they've acquired in one year. In 2005 Eran Broshy cashed out on 608,500 shares for a total of $9,419,917.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MAGELLAN HEALTH SERVICES INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+21.17%
1.69K
—
—
9.64K
May 24
Form 4
+26.85%
2.14K
—
—
10.1K
May 24
Form 4
-37.94%
-4.87K
$80.00
-$389,360.00
7.96K
Scheduled
Feb 23
Form 4
-15.94%
-2.43K
$75.00
-$182,475.00
12.83K
Scheduled
Dec 8
Form 4
+17.70%
2.29K
—
—
15.26K
May 18
Form 4
+20.83%
2.23K
—
—
12.96K
May 20
Form 4
+24.39%
2.1K
—
—
10.73K
May 21
Form 4
+37.82%
2.37K
—
—
8.63K
May 22
Form 4
+27.92%
2.96K
—
—
13.56K
May 16
Form 4
+29.49%
2.41K
—
—
10.6K
May 18
Form 4
+63.75%
3.19K
—
—
8.19K
May 20
Form 4
+475.26%
4.13K
—
—
5K
May 19
Form 4
∞
869
—
—
869
Mar 2
Form 3
—
0
—
—
0
No matching records found

Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.05%
10.54K
—
—
80.56K
May 8
Form 4
+15.00%
9.13K
—
—
70.02K
May 2
Form 4
+19.30%
9.85K
—
—
60.89K
Apr 26
Form 4
+23.85%
9.83K
—
—
51.03K
Apr 27
Form 4
+19.19%
6.63K
—
—
41.21K
Apr 28
Form 4
+32.02%
8.38K
—
—
34.57K
Apr 30
Form 4
+45.48%
8.19K
—
—
26.19K
May 1
Form 4
+50.00%
6K
—
—
18K
May 17
Form 4
+100.00%
6K
—
—
12K
May 3
Form 4
∞
6K
—
—
6K
Apr 22
Form 3/A
—
0
—
—
0
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found

Certara, Inc. (CERT) Snapshot price: $11.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+60.33%
8.66K
—
—
23.02K
May 21
Form 4
+53.42%
5K
$15.81
$79,057.90
14.36K
Aug 21 - Aug 22
Form 4
∞
9.36K
—
—
9.36K
May 23
Form 4
—
0
—
—
0
Jul 13
Form 3
—
0
—
—
0
No matching records found

NEUROGEN CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Sep 25
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Jul 26
Form 4
—
0
—
—
0
Jul 19
Form 3
—
0
—
—
0
No matching records found

UNION STREET ACQUISITION CORP. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found